|
In an innovative collaboration, researchers at the HIV
Center are working with the AIDS Institute of the New York
State Department of Health to conduct a structural intervention
promoting the use of the female condom in agencies throughout
the state.
"The collaboration started
about eight years ago when we began discussions about our
concern that the female condom is a highly underutilized
prevention method," said the study's Principal Investigator
Theresa Exner, Ph.D.
"Our discussion deepened as it became clear that microbicides
are some years down the horizon, and that when they do
arrive on the scene -- in maybe 5 or 10 years – the first
generation is going to be substantially less effective
than condoms. In fact, they will probably be recommended
for use with a condom."
"The female condom gives us an opportunity to frame
a new kind of prevention effort, because it has some
major advantages over other methods."
Since barrier methods will clearly continue to be important
tools for the prevention of HIV, STIs, and unintended pregnancy
for the foreseeable future, HIV Center researchers and
AIDS Institute policymakers began to consider how to best
promote the female condom -- a method that has been proven
highly effective and is widely available yet rarely used.
"The female condom gives us an opportunity to frame
a new kind of prevention effort, because it has some major
advantages over other methods," said Exner. "It is a non-hormonal
form of contraception, and there are many health reasons
that women may have for not wanting to put hormones into
their bodies. Also, many men are used to having women set
the agenda in terms of contraceptive methods, and may be
open to using the female condom if it is presented in that
context." Thus, the female condom may present an important
new frontier in the promotion of "dual protection" against
both unintended pregnancy and HIV and STI infection.
"Our previous research shows that there are fundamental
biases against the female condom, often caused by lack
of information, negative press, and negative word of mouth,"
noted Exner. She ascribed the resulting underutilization
not to deficiencies in the method but rather in its promotion.
"There still has not been a concerted effort to engage
either agency directors or front-line counselors, all of
whom directly deal with issues of sexual risk reduction
and who are in a position to either promote or marginalize
the method. We felt that it was time to put the female
condom on the agenda and to do so by bringing in the key
players who hadn't been part of the picture."
The New York State Female
Condom Promotion Program utilizes the organizational infrastructure,
training, and capacity-building mechanisms already in place
at the AIDS Institute. To date, 30 agencies funded by the
AIDS Institute have been recruited as participants in the
intervention, representing a broad spectrum, including
CBOs primarily engaged in outreach; medical facilities
that provide HIV primary care; HIV case management; contraceptive
or STI services; harm reduction programs, including needle
exchanges; and drug treatment programs. The study is now
about at the halfway point, with approximately 30 more
agencies still to be recruited. The agencies reflect a
geographic spread that roughly mimics the distribution
of the HIV epidemic in New York State, with about two-thirds
in the greater New York City area and one-third throughout
the rest of the state.
Intervening at the Structural Level
As a structural intervention, the New York State Female
Condom Promotion Program goes beyond the usual emphasis
on individuals, couples, or families to address broader
policy development and practical implementation. The study
design compares a basic intervention to an enhanced intervention
(given the clear need for intervention and the efficacy
of the female condom, it was
|
decided not to include a no-treatment control condition).
In both conditions, agencies are provided with subsidized
access to female condoms for one year. In addition, agency
directors are invited to a meeting where the researchers
lay out the empirical evidence on the efficacy of the female
condom as well as on utilization patterns in NYS. At this
meeting, there is also an attempt to develop consensus
about the importance of the project and to gain the commitment
of the directors to promote the female condom within their
agencies. At the end of the meeting, directors are asked
to develop an action plan for female condom promotion for
their specific agency.
In the enhanced intervention, the program additionally
provides a one-day training for sexual risk reduction counselors
at the agency. Further, the researchers provide consultation
and support through monthly phone calls, both to directors
and counselors, to assist them in their action plans for
female condom promotion. For example, if a counselor is
having trouble with helping clients negotiate female condom
use, the researchers would make sure that the counselor
had materials, they might conduct role playing about specific
issues and problem solving, and they might help counselors
to team up with one another or might arrange for more frequent
supervision to be provided.
In another agency, the action plan might include the
decision to make sure that the female condom is reaching
into the community beyond their specific agency. For instance,
some counselors have worked with local pharmacies and the
program has provided them with a cover letter explaining
the study and offering information for the pharmacist about
the female condom. The program has also assisted agencies
with preparing a presentation about the female condom to
their community advisory board.
Research-Government Collaboration
This partnership has brought together a group of HIV
and sexuality researchers with policy leaders in public
health from through New York State. Working with Exner
at the HIV Center are Co-Principal Investigators
Susie Hoffman, Dr.P.H.,
and Joanne Mantell,
Ph.D. and Co-Investigators
Joyce Hunter, D.S.W.
and Jessica
Adams-Skinner, Ed.D.
"The involvement of the AIDS Institute has been critical
to fostering collaboration with agencies throughout
New York State."
At the AIDS Institute, which coordinates all HIV public
health initiatives in New York State, the Co-Principal
Investigator is James Tesoriero, Ph.D., who directs the
Office of Program Evaluation and Research. AIDS Institute
Co-Investigators include Susan Klein, M.S., Deputy Director
for Program Planning, Development, and Evaluation; Alma
Candelas, M.P.H., Associate Director of the Division of
HIV Prevention; and the Director and Assistant Director
of HIV Education and Training Programs, Richard Cotroneo,
M.A., and Dara Shapiro, M.P.H..
"We are such full partners – it has been a privilege
to work with them every step of the way," said Exner. "The
involvement of the AIDS Institute has been critical to
understanding what agencies are out there and what their
missions are, and to facilitating a sense of collaboration
with the agencies who are our study participants throughout
New York State." Because of the close collaboration on
many levels, the intervention, if successful, can be quickly
integrated into existing HIV educational programs throughout
the state, reaping early returns on the research investment.
If successful, the program will demonstrate
that training health care providers is a more effective
way to widely promote the female condom than just offering
agencies access to free female condoms without providing
training. The study may show that one-on-one instruction
can be key to women's successful uptake of the female condom.
The collaboration with the NYS Department of Health in
this effort means that if successful, the program has a
high likelihood of being permanently adopted across the
State and by public health agencies in other high prevalence
regions as well.
For more information,
visit the New York State Department of Health webpage on
the female condom. For a bibliography of published
research on the female condom conducted at the HIV Center,
click here.
|